• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
SHEN Qin,WANG Xiaoping,QIANG Lei.Research progress on the pathogenesis of drug-induced liver injury caused by different drugs[J].Journal Of Pharmaceutical Research,2022,41(9):595-599[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2303times   Download 2215次 QR Code for this article
Scan with your phone!
药物引起的肝损伤发病机制研究进展
沈琴,王晓萍,强磊
Font:Larger+|Default|Smaller-
(中国药科大学基础医学与临床药学学院,天然药物国家重点实验室,江苏 南京 211198)
摘要:
药物性肝损伤(drug-induced liver injury,DILI)是由药物或其代谢产物乃至辅料所引起的肝损伤,是目前临床上常见的药品不良反应之一。药物性肝损伤在我国的发生率偏高,仅次于病毒性肝炎和脂肪性肝病。在欧美,药物性肝损伤是引发肝衰竭的主要原因。尽管人们早已意识到药物性肝损伤的危害,但由于其病因复杂,临床表现不具有特异性,诊断标记物特异性不强,导致药物性肝损伤患者常常无法及时被确诊,最终发展为肝衰竭甚至死亡。已知目前有超过1 100种药物可以在不同程度上引起肝损伤。因此,本文主要总结了不同类型药物诱发肝损伤的不同作用机制,为日后药物性肝损伤的预防和治疗提供了一定的理论基础。
关键词:  药物性肝损伤  分子机制  研究进展
DOI:10.13506/j.cnki.jpr.2022.09.007
基金项目:中央高校基本科研业务费专项资金(No.2632022ZD05)
Publication Date:September 25, 2022
Research progress on the pathogenesis of drug-induced liver injury caused by different drugs
SHEN Qin,WANG Xiaoping,QIANG Lei
(State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China)
Abstract:
Drug-induced liver injury(DILI) is caused by drugs or their metabolites or excipients, which is one of the common adverse drug reactions in clinical practice. DILI has a high incidence in China, second only to viral hepatitis and fatty liver disease. DILI is a leading cause of liver failure in Europe and the United States. Although people have long been aware of the harm of drug-induced liver injury, due to its complex etiology, non-specific clinical manifestations and weak specificity of diagnostic markers, patients with drug-induced liver injury often cannot be diagnosed in time and eventually develop liver failure or even death. More than 1 100 drugs are known to cause liver damage to varying degrees. Therefore, this paper reviewed the pathogenesis of drug-induced liver injury from the perspective of etiology, hoping to give readers a more comprehensive and in-depth understanding of DILI.
Key words:  Drug-induced liver injury  Molecular mechanism  Research progress
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.